Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-003914
Filing Date
2022-03-16
Accepted
2022-03-16 16:08:43
Documents
88
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cyt-20211231.htm   iXBRL 10-K 3099146
2 EX-4.3 cyt-ex4_3.htm EX-4.3 40151
3 EX-23.1 cyt-ex23_1.htm EX-23.1 4146
4 EX-31.1 cyt-ex31_1.htm EX-31.1 18696
5 EX-31.2 cyt-ex31_2.htm EX-31.2 18672
6 EX-32.1 cyt-ex32_1.htm EX-32.1 10899
7 EX-32.2 cyt-ex32_2.htm EX-32.2 10885
8 GRAPHIC img140242155_0.jpg GRAPHIC 27198
9 GRAPHIC img140242155_1.jpg GRAPHIC 32058
10 GRAPHIC img140242155_2.jpg GRAPHIC 408195
11 GRAPHIC img140242155_3.jpg GRAPHIC 18364
12 GRAPHIC img140242155_4.jpg GRAPHIC 94765
13 GRAPHIC img140242155_5.jpg GRAPHIC 28945
14 GRAPHIC img140242155_6.jpg GRAPHIC 43178
15 GRAPHIC img140242155_7.jpg GRAPHIC 66096
16 GRAPHIC img140242155_8.jpg GRAPHIC 107878
  Complete submission text file 0000950170-22-003914.txt   11182133

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cyt-20211231_lab.xml EX-101.LAB 439619
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cyt-20211231_pre.xml EX-101.PRE 332434
19 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cyt-20211231_cal.xml EX-101.CAL 42985
20 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cyt-20211231_def.xml EX-101.DEF 177896
21 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cyt-20211231.xsd EX-101.SCH 50450
82 EXTRACTED XBRL INSTANCE DOCUMENT cyt-20211231_htm.xml XML 1429070
Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40499 | Film No.: 22744958
SIC: 2834 Pharmaceutical Preparations